State of Possible Podcast – Episode 3: The Unprecedented Nature of COVID-19 Vaccine Development & Distribution

Nov 16, 2020

The COVID-19 pandemic remains the number one health concern around the globe as we await approval of multiple vaccines. There are still many unanswered questions and challenges that lie ahead for the biopharma industry, health stakeholders, and government, particularly around development, prioritization, and distribution of the vaccines. Podcast host Bob Coughlin and his guests, Clement Lewin, Head of BARDA Office & New Vaccines at Sanofi Pasteur, and Dr. Kelly Moore, Associate Director of the Immunization Action Coalition & Adjunct Associate Professor at Vanderbilt University Medical Center, discuss these timely issues.

Thank you to our generous sponsors: Thermo Fisher Scientific, Morgan Stanley, and Marsh & McLennan Agency.

See all MassBio News